Literature DB >> 9794392

B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.

Y Pewzner-Jung1, D Friedmann, E Sonoda, S Jung, K Rajewsky, D Eilat.   

Abstract

To study the relative contributions of clonal deletion, clonal anergy, and receptor editing to tolerance induction in autoreactive B cells and their dependence on B cell receptor affinity, we have constructed "knock in" mice in which germline encoded or somatically mutated, rearranged anti-DNA heavy (H) chains were targeted to the H chain locus of the mouse. The targeted H chains were expressed on the vast majority of bone marrow (BM) and splenic B cells and were capable of Ig class switching and the acquisition of somatic mutations. A quantitative analysis of B cell populations in the BM as well as of Jkappa utilization and DNA binding of hybridoma Abs suggested that immature B cell deletion and light (L) chain editing were the major mechanisms affecting tolerance. Unexpectedly, these mechanisms were less effective in targeted mice expressing the somatically mutated, anti-DNA H chain than in mice expressing the germline-encoded H chain, possibly due to the greater abundance of high affinity, anti-DNA immature B cells in the BM. Consequently, autoreactive B cells that showed features of clonal anergy could be recovered in the periphery of these mice. Our results suggest that clonal deletion and receptor editing are interrelated mechanisms that act in concert to eliminate autoreactive B cells from the immune system. Clonal anergy may serve as a back-up mechanism for central tolerance, or it may represent an intermediate step in clonal deletion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794392

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  B cell tolerance and positive selection in lupus.

Authors:  Dan Eilat; Matthias Wabl
Journal:  J Immunol       Date:  2012-07-15       Impact factor: 5.422

Review 4.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  Loss of an IgG plasma cell checkpoint in patients with lupus.

Authors:  Jolien Suurmond; Yemil Atisha-Fregoso; Emiliano Marasco; Ashley N Barlev; Naveed Ahmed; Silvia A Calderon; Mei Yin Wong; Meggan C Mackay; Cynthia Aranow; Betty Diamond
Journal:  J Allergy Clin Immunol       Date:  2018-11-13       Impact factor: 10.793

Review 6.  Mechanisms of central tolerance for B cells.

Authors:  David Nemazee
Journal:  Nat Rev Immunol       Date:  2017-04-03       Impact factor: 53.106

7.  BAFF/APRIL inhibition decreases selection of naive but not antigen-induced autoreactive B cells in murine systemic lupus erythematosus.

Authors:  Weiqing Huang; Ioana Moisini; Ramalingam Bethunaickan; Ranjit Sahu; Meredith Akerman; Dan Eilat; Martin Lesser; Anne Davidson
Journal:  J Immunol       Date:  2011-11-18       Impact factor: 5.422

8.  Reversing Tolerance in Isotype Switch-Competent Anti-Insulin B Lymphocytes.

Authors:  Jonathan M Williams; Rachel H Bonami; Chrys Hulbert; James W Thomas
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

9.  A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation.

Authors:  Rebecca A Sweet; Sean R Christensen; Michelle L Harris; Jonathan Shupe; Jaime L Sutherland; Mark J Shlomchik
Journal:  Autoimmunity       Date:  2010-04-07       Impact factor: 2.815

10.  Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies.

Authors:  Lars Hangartner; Beatrice M Senn; Birgit Ledermann; Ulrich Kalinke; Peter Seiler; Etienne Bucher; Raphaël M Zellweger; Katja Fink; Bernhard Odermatt; Kurt Bürki; Rolf M Zinkernagel; Hans Hengartner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.